drugset / Trial / NCT00594958

Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51

NCT00594958

Phase 3 Completed 639 enrolled Valneva Austria GmbH
RandomizedParallel-groupDouble-blindPrevention

Summary

The objective is to demonstrate equivalence of three IC51 batches in terms of Geometric Mean Titers for anti-JEV neutralizing antibody.

Timeline

Start
2006-09
Primary completion
2007-04
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator IC51 Vaccine 6 ug Intramuscular
Comparator IC51 Vaccine 0.5 ml Intramuscular

Indications